Director/PDMR Shareholding

RNS Number : 7250D

Hikma Pharmaceuticals Plc

28 April 2017

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Michael Raya
2	Reason for the notification
a)	Position/status	CEO of West-Ward Pharmaceuticals
b)	Initial notification /Amendment	Amendment
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Purchase of 10,272 shares in the Company in compliance with the Company's shareholding requirement.
c)	Price(s) and volume(s)	Price(s): £18.689 Volume(s): 10,272
d)	Aggregated information	Price(s): £18.689 Volume(s): 10,272 Total: £191,973.41
e)	Date of the transaction	26 April 2017
f)	Place of the transaction	London Stock Exchange (XLON)

 

END

 

 

DSHBDGDSUUDBGRI